Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > waiting for NR

<< Previous

Bullboard Posts

Next >>

Comment by eSnowdenon Apr 05, 2018 4:43pm

92 Views

Post# 27838837

RE:waiting for NR

hi juansito, please don't rely on informations from other peoples, what they provide is false and misleading...I always tell the truth. Now, as for your question regarding why ICO not move, I will provide the honest & factual informations to you, as always. The simple answer to your question is the following--ICO have limited financial resources & desperately need cash. Thank you for listening.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"